Facetten
Zugriff
Einrichtung
Medientyp
- Text 15
Karte
Erscheinungsjahr
Autor/in
- Gluz, Oleg
- Christgen, Matthias 8
- Graeser, Monika 7
- Grischke, Eva-Maria 7
- Kuemmel, Sherko 7
- alle zeigen
Sprache
15 Einträge gefunden
-
Impact of RNA signatures on pCR and survival after 12-week neoadjuvant pertuzumab plus trastuzumab with or without paclitaxel in the WSG-ADAPT-HER2+/HR- trial
- Graeser, Monika
- Gluz, Oleg
- Biehl, Claudia
- Ulbrich-Gebauer, Daniel
- Christgen, Matthias
- Palatty, Jenci
- Kuemmel, Sherko
-
Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone Receptor-Positive/ERBB2-Positive Early Breast Cancer:The Neoadjuvant WSG-TP-II Randomized Clinical Trial
- Gluz, Oleg
- Nitz, Ulrike A
- Christgen, Matthias
- Kuemmel, Sherko
- Holtschmidt, Johannes
- Schumacher, Johannes
- Hartkopf, Andreas
-
Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer:an international pooled analysis of individual patient data from four prospective observational studies
- Yamamoto, Yutaka
- Yamashiro, Hiroyasu
- Schneeweiss, Andreas
- Müller, Volkmar
- Gluz, Oleg
- Klare, Peter
- Aktas, Bahriye
-
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial
- Nitz, Ulrike
- Gluz, Oleg
- Graeser, Monika
- Christgen, Matthias
- Kuemmel, Sherko
- Grischke, Eva-Maria
- Braun, Michael
-
-
De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial
- Gluz, Oleg
- Nitz, Ulrike
- Kolberg-Liedtke, Cornelia
- Prat, Aleix
- Christgen, Matthias
- Kuemmel, Sherko
- Mohammadian, Mohammad Parsa
-
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer
- Grote, Isabel
- Bartels, Stephan
- Christgen, Henriette
- Radner, Martin
- Gronewold, Malte
- Kandt, Leonie
- Raap, Mieke
-
Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12-week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials: Combined analysis from the WSG ADAPT subtrials
- Graeser, Monika
- Schrading, Simone
- Gluz, Oleg
- Strobel, Kevin
- Würstlein, Rachel
- Kümmel, Sherko
- Schumacher, Claudia
-
Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials
- Graeser, Monika
- Schrading, Simone
- Gluz, Oleg
- Strobel, Kevin
- Herzog, Christopher
- Umutlu, Lale
- Frydrychowicz, Alex
-
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial
- Graeser, Monika
- Feuerhake, Friedrich
- Gluz, Oleg
- Volk, Valery
- Hauptmann, Michael
- Jozwiak, Katarzyna
- Christgen, Matthias
-
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials
- Graeser, Monika
- Harbeck, Nadia
- Gluz, Oleg
- Würstlein, Rachel
- Zu Eulenburg, Christine
- Schumacher, Claudia
- Grischke, Eva-Maria
-
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer
- Grote, Isabel
- Bartels, Stephan
- Kandt, Leonie
- Bollmann, Laura
- Christgen, Henriette
- Gronewold, Malte
- Raap, Mieke
-
San Antonio 2016: Progress on the Long Way to Individualized Treatment of Breast Cancer
2017 - Forschungsinformationssystem des UKE -
HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer
- Harbeck, Nadia
- Beckmann, Matthias W
- Rody, Achim
- Schneeweiss, Andreas
- Müller, Volkmar
- Fehm, Tanja
- Marschner, Norbert
-
Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive metastatic breast cancer.
- Kröger, Nicolaus
- Frick, Markus
- Gluz, Oleg
- Mohrmann, Svjetlana
- Metzner, Bernd
- Jackisch, Christian
- Ko, Yon